tDCS in Treatment of Craving in Sexual Addiction
CAS
Transcranial Electrical Stimulation in Sexual Addiction: an Innovative Treatment for a Better Understanding of the Physiopathology of Craving
1 other identifier
interventional
50
0 countries
N/A
Brief Summary
In patients with addiction to a substance, an increase in activity in the prefrontal cortex induced by transcranial Direct Current Stimulation -tDCS (non-invasive technique, modulating cortical activity by applying low-intensity electrical currents between two electrodes),may help reduce craving in people addicted to alcohol and tobacco. By analogy with addictive behavior with a substance, the craving observed in certain behavioral addictions would involve the same neural circuits. The main hypothesis is to reduce the sexual craving associated with the viewing of erotic images during active brain stimulation compared to placebo stimulation. Functional MRI will allow to better understand the neural circuits involved in sexual addiction and in the expected inhibition of sexual arousal by tDCS in sexual addictions during visualization erotic images.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2021
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 22, 2021
CompletedFirst Posted
Study publicly available on registry
June 11, 2021
CompletedStudy Start
First participant enrolled
July 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2024
CompletedJune 11, 2021
November 1, 2020
2.3 years
March 22, 2021
June 9, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Efficacy of tDCS in treatment of craving of sexual addiction
The primary outcome is to assess the effectiveness of tDCS treatment on the reduction of the craving by comparing before and after active tDCS stimulation in response to erotic-pornographic images. Efficacy will be quantified by a sexual craving scale associated with erotico-pornographic images before and after tDCS stimulation. A significant decrease in craving and score on the scale is expected after tDCS stimulation. compared to control subjects. Images of social and neutral interactions will be used as comparison of expected changes. The scale used is the PATHOS scale: brief sexual addiction screening questionnaire.
3 years
Efficacy of tDCS in treatment of sexual addiction in subjective emotional response
For the evaluation of efficacy of tDCS in emotional response, indirect measurement of craving, visual emotional responses scales (Likert) will be used during visualization of erotico-pornographic images, before and after stimulation. The "desire" will be quantified on a Likert scale from 0 to 7.
3 years
Efficacy of tDCS in treatment of sexual addiction in objective emotional response
An assessment of emotional responses will also be done using heart rate measure during visualization of images in fMRI, before and after stimulation by tDCS
3 years
Secondary Outcomes (4)
Brain structures involved in sexual addiction
3 years
Evaluation of Impulsivity with The Barratt Impulsiveness Scale
3 years
Evaluation of Impulsivity with UPPS-P Impulsive Behavior Scale
3 years
Evaluation Evaluation of Impulsivity with Stop Signal Task
3 years
Study Arms (2)
Patient with sexual addiction - active stimulation
ACTIVE COMPARATOR25 patients with sexual addiction will be stimulated by active tDCS during 5 consecutive days
Patient with sexual addiction - sham stimulation (placebo)
SHAM COMPARATOR25 patients with sexual addiction will be stimulated by sham tDCS stimulation (placebo) during 5 consecutive days
Interventions
5 active sessions (1/day for 5 consecutive days) of tDCS (NeuroConn DC), active anode 8cm2 on right dorso-lateral prefrontal cortex and neutral cathode, 2 mA, during 30 min will be performed
5 placebo sessions (1/day for 5 consecutive days) of sham tDCS (NeuroConn DC), anode 8cm2 on right dorso-lateral prefrontal cortex and neutral cathode during 30min will be performed
Eligibility Criteria
You may qualify if:
- year old male
- Heterosexual
- Right-handed (Manual laterality test)
- With a sexual addiction (PEACCE Tool\> 3 and Carnes ≥ 13/25) except for controls
- Having signed a written and informed consent
- Subject benefiting from social security
You may not qualify if:
- Subject presenting a medical pathology requiring drug treatment,
- Severe psychiatric pathology (bipolar disorder, hyperactivity or schizophrenia) or another addiction (alcohol, illicit substances or behavioral addiction)
- Subject consuming psychotropic drugs in progress or during the last month
- Subject not understanding French
- Subject under tutorship or curatorship
- Subjects with neurological disease including epilepsy or a history of head trauma
- Subjects hospitalized in enforced hospitalization
- Subject presenting a contraindication to tDCS: subject with an electrical or metal brain implant
- Subject with a contraindication to MRI
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (6)
Garcia FD, Thibaut F. Sexual addictions. Am J Drug Alcohol Abuse. 2010 Sep;36(5):254-60. doi: 10.3109/00952990.2010.503823.
PMID: 20666699BACKGROUNDMalandain L, Blanc JV, Ferreri F, Thibaut F. Pharmacotherapy of Sexual Addiction. Curr Psychiatry Rep. 2020 May 7;22(6):30. doi: 10.1007/s11920-020-01153-4.
PMID: 32377953BACKGROUNDWainberg ML, Muench F, Morgenstern J, Hollander E, Irwin TW, Parsons JT, Allen A, O'Leary A. A double-blind study of citalopram versus placebo in the treatment of compulsive sexual behaviors in gay and bisexual men. J Clin Psychiatry. 2006 Dec;67(12):1968-73. doi: 10.4088/jcp.v67n1218.
PMID: 17194276BACKGROUNDVolkow ND, Wang GJ, Fowler JS, Tomasi D, Telang F. Addiction: beyond dopamine reward circuitry. Proc Natl Acad Sci U S A. 2011 Sep 13;108(37):15037-42. doi: 10.1073/pnas.1010654108. Epub 2011 Mar 14.
PMID: 21402948BACKGROUNDVoon V, Mole TB, Banca P, Porter L, Morris L, Mitchell S, Lapa TR, Karr J, Harrison NA, Potenza MN, Irvine M. Neural correlates of sexual cue reactivity in individuals with and without compulsive sexual behaviours. PLoS One. 2014 Jul 11;9(7):e102419. doi: 10.1371/journal.pone.0102419. eCollection 2014.
PMID: 25013940BACKGROUNDRosenberg KP, Carnes P, O'Connor S. Evaluation and treatment of sex addiction. J Sex Marital Ther. 2014;40(2):77-91. doi: 10.1080/0092623X.2012.701268. Epub 2013 Jun 21.
PMID: 23790248BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Masking Details
- Depending on the randomized group, the subject will receive one of two treatments 15 days apart (A: active anode on the right DLPFC and neutral cathode on the left shoulder; B: inactive anode on the DLPFC and inactive cathode on the left shoulder). The groups are defined as follows: The results of randomization will not be known by the evaluator.
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 22, 2021
First Posted
June 11, 2021
Study Start
July 1, 2021
Primary Completion
November 1, 2023
Study Completion
October 1, 2024
Last Updated
June 11, 2021
Record last verified: 2020-11
Data Sharing
- IPD Sharing
- Will not share